ArticleScientific reports2025
Early detection of Alzheimer's disease progression stages using hybrid of CNN and transformer encoder models.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A survey of deep learning techniques in detecting neurological disorders using MRI.Biomedical engineering online · 2026Pooled it
- Lightweight Vision Transformer with transfer learning for interpretable Alzheimer's disease severity assessment.Scientific reports · 2025Article
- Enhanced early skin cancer detection through fusion of vision transformer and CNN features using hybrid attention of EViT-Dens169.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder that affects memory and cognitive functions. Manual diagnosis is prone to human error, often leading to misdiagnosis or delayed detection. MRI techniques help visualize the fine tissues of the brain cells, indicating the stage of disease progression. Artificial intelligence techniques analyze MRI with high accuracy and extract subtle features that are difficult to diagnose manually. In this study, a modern methodology was designed that combines the power of CNN models (ResNet101 and GoogLeNet) to extract local deep features and the power of Vision Transformer (ViT) models to extract global features and find relationships between image spots. First, the MRI images of the Open Access Imaging Studies Series (OASIS) dataset were improved by two filters: the adaptive median filter (AMF) and Laplacian filter. The ResNet101 and GoogLeNet models were modified to suit the feature extraction task and reduce computational cost. The ViT architecture was modified to reduce the computational cost while increasing the number of attention vertices to further discover global features and relationships between image patches. The enhanced images were fed into the proposed ViT-CNN methodology. The enhanced images were fed to the modified ResNet101 and GoogLeNet models to extract the deep feature maps with high accuracy. Deep feature maps were fed into the modified ViT model. The deep feature maps were partitioned into 32 feature maps using ResNet101 and 16 feature maps using GoogLeNet, both with a size of 64 features. The feature maps were encoded to recognize the spatial arrangement of the patch and preserve the relationship between patches, helping the self-attention layers distinguish between patches based on their positions. They were fed to the transformer encoder, which consisted of six blocks and multiple vertices to focus on different patterns or regions simultaneously. Finally, the MLP classification layers classify each image into one of four dataset classes. The improved ResNet101-ViT hybrid methodology outperformed the GoogLeNet-ViT hybrid methodology. ResNet101-ViT achieved 98.7% accuracy, 95.05% AUC, 96.45% precision, 99.68% sensitivity, and 97.78% specificity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.